Jérôme Boursier,Marie Decraecker,Marc Bourlière et al.
Jérôme Boursier et al.
Liver elastography offers the possibility of a quick, non-invasive, and painless evaluation of the liver with immediate results at bedside. Transient elastography is the most validated technology, and many others such as point shear wave el...
Assessment of Lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia - Randomized placebo controlled trial [0.03%]
枯草杆菌-乳酸菌二联活菌对胆道闭锁患儿的疗效评估：随机双盲对照研究
Ewa Orłowska,Piotr Czubkowski,Katarzyna Wołochowska et al.
Ewa Orłowska et al.
Background: The role of microbiota in biliary atresia (BA) remains unclear. The aim of our study was to assess efficacy and safety of LGG treatment in children with BA after HPE with special focus on bacterial cholangitis...
Randomized Controlled Trial
Clinics and research in hepatology and gastroenterology. 2021 Nov;45(6):101753. DOI:10.1016/j.clinre.2021.101753 2021
Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease [0.03%]
非酒精性脂肪肝病儿童纤维化和脂肪变性的无创评估
Bryan R Chen,Calvin Q Pan
Bryan R Chen
Background and aims: Non-Alcoholic Fatty Liver Disease (NAFLD) has become one of the most common causes of chronic liver disease in the pediatric population. Recent advances have been made in developing non-invasive measu...
François Villeret,Jérôme Dumortier,Domitille Erard-Poinsot
François Villeret
Liver steatosis is the hepatic manifestation of the metabolic syndrome, and is now the leading cause of chronic liver disease worldwide. The treatment of metabolic cirrhosis with liver failure and/or hepatocellular carcinoma is liver transp...
Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review [0.03%]
严重COVID-19形式下的肝损伤的病理生理和分子机制：整合式综述
Jorge Lucas de Sousa Moreira,Sarah Maria Bacurau Barbosa,Jucier Gonçalves Júnior
Jorge Lucas de Sousa Moreira
Background and aims: SARS-CoV-2 has primary pulmonary impairment, but other organs such as the liver can also be affected. This implies a worsening of patient's prognosis and an increase in morbidity and mortality. The me...
Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study [0.03%]
代谢健康与不健康肥胖与肝纤维化进展的相关性：横断面研究
Helda Tutunchi,Fatemeh Naeini,Mehrangiz Ebrahimi-Mameghani et al.
Helda Tutunchi et al.
Background: The development of liver fibrosis is the most important predictor of adverse outcomes in patients with non-alcoholic fatty liver disease (NAFLD). Little is known regarding the risk factors for the progression ...
Neonatal cholestasis and Niemann-pick type C disease: A literature review [0.03%]
新生儿胆汁淤积与尼曼-匹克病C的文献回顾
L López de Frutos,J J Cebolla,I de Castro-Orós et al.
L López de Frutos et al.
Background: Neonatal cholestasis (NC) is one of the most serious diseases in newborns and infants and results from metabolic disorders, such as Niemann-Pick type C (NPC), among other causes. ...
Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women [0.03%]
血管性肝病对育龄妇女月经周期和代谢状态的影响
Tatiana Stempak-Droissart,Christine Rousset-Jablonski,Poli M Spritzer et al.
Tatiana Stempak-Droissart et al.
Background: Vascular liver disease (VLD) are rare liver diseases, which affect women at reproductive ages. Main complications are bleeding (portal hypertension, thrombopenia or anticoagulation related) and thromboembolism...
Comparison of Interferon-α-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B [0.03%]
比较干扰素与核苷(酸)类似物抗病毒预防慢性乙肝不良转归的风险效应分析
Qian-Guo Mao,Hui-Qing Liang,Ya-Lin Yin et al.
Qian-Guo Mao et al.
Background: Whether interferon (IFN)-α therapy is better than nucleos(t)ide analogs (NAs) in the prevention of adverse outcomes, including hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is stil...
Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis [0.03%]
代谢综合征与结直肠腺瘤风险的系统评价和meta分析
Huadong Wu,Jinjia Zhang,Baojun Zhou
Huadong Wu
Objective: Whether metabolic syndrome is a risk factor of colorectal adenoma has spurred debate. We systematically meta-analyzed all clinical studies associated with metabolic syndrome (MetS)/metabolic components and colo...